GLUE vs TPR · rev $13.2M vs P/E 46, rev $8.00B
Monte Rosa Therapeutics Inc (GLUE) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
GLUE currently screens at market cap $1.56B. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the GLUE and TPR stock pages for the full models.
Not investment advice.